MedTrace Logo

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

NCT00897481 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future.

PURPOSE: This laboratory study is looking at tumor tissue samples from patients with melanoma who have undergone sentinel lymph node biopsy.

Conditions

  • Melanoma (Skin)

Interventions

GENETIC

gene expression analysis

GENETIC

mutation analysis

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunohistochemistry staining method

PROCEDURE

sentinel lymph node biopsy

Sponsors & Collaborators

  • Leeds Cancer Centre at St. James's University Hospital

    lead OTHER

Principal Investigators

  • Julia Newton Bishop, MD · Leeds Cancer Centre at St. James's University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2011-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897481 on ClinicalTrials.gov